전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
imunogeninis poveikis
immunogenicity
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
imunogeninis poveikis.)
(see immunogenicity.)
마지막 업데이트: 2012-04-11
사용 빈도: 4
품질:
zostavax imunogeninis poveikis
immunogenicity of zostavax
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
gali pasireikšti imunogeninis poveikis.
there is potential for immunogenicity.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
ištiriamas galimas imunogeninis ir imunotoksinis poveikis.
potential immunogenic and immunotoxic effects shall be studied.
마지막 업데이트: 2014-11-21
사용 빈도: 1
품질:
imunogeninis iblias poveikis buvo vertinamas anksčiau gydytiems pacientams.
the immunogenicity of iblias was evaluated in previously treated patients.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
imunogeniškumas ir imunotoksiškumas. ištiriamas galimas imunogeninis ir imunotoksinis poveikis.
immunogenicity and immunotoxicity: potential immunogenic and immunotoxic effects shall be studied.
마지막 업데이트: 2014-11-21
사용 빈도: 1
품질:
kaip ir prieš visus terapinius baltymus, gali pasireikšti imunogeninis poveikis.
as with all therapeutic proteins, there is potential for immunogenicity.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
kai ir vartojant bet kokių gydymui skirtų baltymų, gali pasireikšti imunogeninis poveikis.
as with all therapeutic proteins, there is a potential for immunogenicity.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
vartojant gydomuosius baltymus, pavyzdžiui, ofatumumabą, yra tikimybė, kad pasireikš imunogeninis poveikis.
there is a potential for immunogenicity with therapeutic proteins such as ofatumumab.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
kaip ir vartojant bet kokių gydomąjį poveikį sukeliančių baltymų, gydymo zaltrap metu gali pasireikšti imunogeninis poveikis.
as with all therapeutic proteins, there is a potential for immunogenicity with zaltrap.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
visuose šiuose tyrimuose buvo tiriamas vakcinos gebėjimas paskatinti h5n1 viruso antikūnų gamybą (imunogeninis poveikis).
all of the studies looked at the ability of the vaccine to trigger the production of antibodies (‘immunogenicity’) against h5n1.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
Įrodyta, kad praėjus šešioms savaitėms po vienkartinės vakcinos dozės sušvirkštimo, dabartinės šaldytuve stabilios formos imunogeninis poveikis panašus į ankstesnės proquad formos.
immunogenicity immunogenicity was studied in children 12 through 23 months of age with a negative clinical history of measles, mumps, rubella, and varicella who participated in 5 randomized clinical trials. the immunogenicity of the current refrigerator-stable formulation was shown to be similar to the immunogenicity of the earlier formulation of proquad six weeks after a single dose of the vaccine.
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
zostavax imunogeninis poveikis imuninis atsakas po vakcinacijos tirtas pslelins profilaktikos tyrimo (shingles prevention study sps) 1 395 tiriamj pogrupyje.
immunogenicity of zostavax within the shingles prevention study (sps) , immune responses to vaccination were evaluated in a subset of the enrolled subjects (n=1395) .
마지막 업데이트: 2008-03-04
사용 빈도: 2
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
zostavax imunogeninis poveikis imuninis atsakas po vakcinacijos tirtas pūslelinės profilaktikos tyrimo (shingles prevention study – sps) 1 395 tiriamųjų pogrupyje.
immunogenicity of zostavax within the shingles prevention study (sps), immune responses to vaccination were evaluated in a subset of the enrolled subjects (n=1395).
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
imunogeninis vienkartinės ankstesnės formos proquad dozės poveikis buvo lygintas su imunogeniniu atskirų vakcinos dalių (vėjaraupių gyvosios vakcinos (oka/merck) ir vakcinos nuo tymų, kiaulytės, raudonukės, pagamintos merck & co., inc.) vienkartinių dozių, kurios šiuo metu keliose šalyse vartojamos įprastiniam skiepijimui, poveikiu.
the immunogenicity of a single dose of an earlier formulation of proquad was comparable to the immunogenicity of a single dose of its individual component vaccines (varicella vaccine live (oka/merck) and the measles, mumps, and rubella vaccine manufactured by merck & co., inc.), currently used in routine vaccination in some countries.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
경고: 보이지 않는 HTML 형식이 포함되어 있습니다